Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 341

1.

Guidelines for reporting of statistics for clinical research in urology.

Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, Vickers AJ.

BJU Int. 2018 Dec 8. doi: 10.1111/bju.14640. [Epub ahead of print] Review.

PMID:
30537407
3.

Innovations in Statistical Review at European Urology.

Assel M, Sjoberg DD, Catto JWF, Vickers AJ.

Eur Urol. 2018 Oct 13. pii: S0302-2838(18)30736-X. doi: 10.1016/j.eururo.2018.09.046. [Epub ahead of print]

PMID:
30327270
4.

Clinical Utility of Prostate and Tumor Volume-Related Parameters Following Radical Prostatectomy for Localized Prostate Cancer.

Ito Y, Udo K, Vertosick EA, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW.

J Urol. 2018 Oct 6. pii: S0022-5347(18)43967-5. doi: 10.1016/j.juro.2018.09.060. [Epub ahead of print]

PMID:
30300632
5.

Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis.

Vickers AJ.

Clin Chem. 2018 Oct 1. pii: clinchem.2018.287094. doi: 10.1373/clinchem.2018.287094. [Epub ahead of print] No abstract available.

PMID:
30274977
6.

Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device.

Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Donahue TF, Dalbagni G, Herr HW, Bochner BH, Vickers AJ, Donat SM.

Urology. 2018 Sep 20. pii: S0090-4295(18)30967-1. doi: 10.1016/j.urology.2018.09.010. [Epub ahead of print]

PMID:
30244117
7.

Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening.

Kim SJ, Vickers AJ, Hu JC.

JAMA Oncol. 2018 Sep 13. doi: 10.1001/jamaoncol.2018.4160. [Epub ahead of print] No abstract available.

PMID:
30242308
8.

Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators.

Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW.

Eur Urol. 2018 Dec;74(6):796-804. doi: 10.1016/j.eururo.2018.08.038. Epub 2018 Sep 19. Review.

PMID:
30241973
9.

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.

Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA, Wilson KM.

Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30627-4. doi: 10.1016/j.eururo.2018.08.032. [Epub ahead of print]

PMID:
30237027
10.

Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.

Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, Mulhall JP.

Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30641-9. doi: 10.1016/j.eururo.2018.08.039. [Epub ahead of print]

PMID:
30237021
11.

Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.

Capogrosso P, Capitanio U, Vertosick EA, Ventimiglia E, Chierigo F, Oreggia D, Moretti D, Briganti A, Vickers AJ, Montorsi F, Salonia A.

Urology. 2018 Aug 20. pii: S0090-4295(18)30783-0. doi: 10.1016/j.urology.2018.07.028. [Epub ahead of print]

PMID:
30138683
12.

Clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer.

Dean LW, Assel M, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Ehdaie B, Fine SW.

J Urol. 2018 Aug 1. pii: S0022-5347(18)43632-4. doi: 10.1016/j.juro.2018.07.062. [Epub ahead of print]

PMID:
30076908
13.

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.

Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, Blinder VS, Zhi WI, Li Q, Vahdat LT, Dickler MN, Robson ME, Mao JJ.

Eur J Cancer. 2018 Sep;101:12-19. doi: 10.1016/j.ejca.2018.06.008. Epub 2018 Jul 13.

PMID:
30007894
14.

Prognosis, Effect Modification, and Mediation.

Vickers AJ, Steineck G.

Eur Urol. 2018 Sep;74(3):243-245. doi: 10.1016/j.eururo.2018.05.027. Epub 2018 Jun 13. No abstract available.

PMID:
29908877
15.

Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups.

Vickers AJ, Vertosick EA, Sjoberg DD.

Eur Urol. 2018 Oct;74(4):535-536. doi: 10.1016/j.eururo.2018.05.032. Epub 2018 Jun 11. No abstract available.

PMID:
29903434
16.

Pharmacogenomics of antioxidant supplementation to prevent age-related macular degeneration.

Vickers AJ.

Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5639. doi: 10.1073/pnas.1803536115. Epub 2018 Jun 7. No abstract available.

PMID:
29880714
17.

Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancer.

Kovac E, Vertosick EA, Sjoberg DD, Vickers AJ, Stephenson AJ.

BJU Int. 2018 Dec;122(6):1003-1009. doi: 10.1111/bju.14418. Epub 2018 Jun 22.

PMID:
29802773
18.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

PMID:
29778349
19.

Reply.

Vickers AJ.

Ophthalmology. 2018 May;125(5):e35. doi: 10.1016/j.ophtha.2017.12.017. No abstract available.

PMID:
29681305
20.

Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.

Sjoberg DD, Vickers AJ, Assel M, Dahlin A, Poon BY, Ulmert D, Lilja H.

Eur Urol. 2018 Jun;73(6):941-948. doi: 10.1016/j.eururo.2018.02.016. Epub 2018 Mar 5.

PMID:
29519548

Supplemental Content

Loading ...
Support Center